(Q41861314)

13 October 2017

0 references

A renal variant of Fabry disease: A case with a novel Gal A hemizygote mutation (English)

1 reference

13 October 2017

1 reference

Jorge H Mukdsi

1

1 reference

13 October 2017

Silvina Gutiérrez

2

1 reference

13 October 2017

Belén Barrón

3

1 reference

13 October 2017

Pablo Novoa

4

1 reference

13 October 2017

Segundo Fernández

5

1 reference

13 October 2017

Ana B de Diller

6

1 reference

13 October 2017

Alicia I Torres

7

1 reference

13 October 2017

Richard N Formica

8

1 reference

13 October 2017

Marcelo Orías

9

1 reference

13 October 2017

1 October 2012

1 reference

Journal of nephropathology

13 October 2017

1 reference

13 October 2017

1

1 reference

13 October 2017

3

1 reference

13 October 2017

194-197

1 reference

Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886146

Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886146

Chloroquine-induced lipidosis mimicking Fabry disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886146

Amiodarone pulmonary toxicity: functional and ultrastructural evaluation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886146

Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886146

Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886146

Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3886146

Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24475416

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Alpha-galactosidase activity should be examined in patients with proteinuria: what have we learned from a family affected with Fabry disease?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24475416

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.5812/NEPHROPATHOL.8123

1 reference

13 October 2017

1 reference

13 October 2017

1 reference